-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704. Cellular Immunotherapies: Clinical: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 13, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Wolfgang A Bethge1*, Peter Martus, PhD2*, Michael Schmitt, MD3, Udo Holtick, MD, PhD4*, Peter Borchmann, MD5, Marion Subklewe, MD6, Kai Rejeski, MD7, Bastian von Tresckow8, Francis A. Ayuk, MD9,10*, Nicolaus Kroeger, MD11, Eva-Maria Wagner-Drouet, MD12*, Gerald Wulf, MD13*, Reinhard Marks, MD14*, Olaf Penack, MD15*, Ulf Schnetzke, MD16*, Christian Koenecke, MD17*, Malte Von Bonin, MD18*, Matthias Stelljes, MD19, Bertram Glass20*, Claudia D. Baldus, MD21, Vladan Vucinic, MD22*, Dimitrios Mougiakakos, MD23*, Max Topp24, Daniel Wolff, MD25*, Roland Schroers, MD26*, Simone Thomas, MD27*, Dietrich W. Beelen, MD28, Claudia Lengerke, MD29 and Peter Dreger, MD3

1Abteilung II fuer Onkologie, Haematologie, Immunologie, Rheumatologie und Pulmologie, Medizinische Universitaetsklinik, Tuebingen, Germany
2Institute for Clinical Epidemiology and Applied Biometrics, University Hospital Tuebingen, Tuebingen, Germany
3Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
4Department of Internal Medicine I, Leukapheresis and Stem Cell Transplant Unit, University Hospital of Cologne, Cologne, Germany
5Klinikum Der Universitaet Zu Koeln, Koeln, Germany
6Department of Medicine III, University Hospital, LMU Munich, Muenchen, Germany
7Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
8Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
9Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
10Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany
11University Medical Center Hamburg-Eppendorf, Hamburg, Germany
12Department of Hematology, Oncology, Pneumology, Medical Clinic III, UCT Johannes Gutenberg-University, Mainz, Germany
13Department of Hematology and Oncology, Georg-August-University of Göttingen, Göttingen, Germany
14University Hospital Freiburg Internal Medicine I, Freiburg im Breisgau, Germany
15Department of Hematology, Oncology, and Tumor Immunology, Charité –Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
16Klinik für Innere Medizin II, Abt. Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany
17Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
18Department of Internal Medicine I, University Hospital 'Carl Gustav Carus', TU Dresden, Dresden, Germany
19Department of Medicine A, Hematology, Oncology and Pneumology, University of Muenster, Muenster, Germany
20Clinic for Hematology, Oncology, Tumorimmunology and Palliative Care, Helios Clinic Berlin-Buch, Berlin, Germany
21Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany
22Clinic and Policlinic for Hematology and Cellular Therapy, University of Leipzig Medical Center, Leipzig, Germany
23Department of Internal Medicine 5, Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
24Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
25Medical Clinic III, University Hospital Regensburg, Regensburg, Germany
26Medizinische Universitätsklinik Ruhr-Universität-Bochum, Knappschaftskrankenhaus, Bochum, Germany
27Regensburg Center for Interventional Immunology, Regensburg, Germany
28Department of Bone Marrow Transplantation, West German Cancer Center, University of Duisburg-Essen, Essen, Germany
29Internal Medicine II (Hematology, Oncology, Clinical Immunology and Rheumatology), University Hospital Tübingen, Tübingen, Germany

Claire Roddie, PhD, MD1*, Juliana Dias1*, Maeve A O'Reilly, MBBCHBAO, MD(Res)2, Amaia Cadinanos Garai, BSc MSc1*, Louisa Green, BSc1*, Mahnaz Abbasian1*, Marina Mitsikakou, BSc; MSc1*, Mhairi Vaughan, BSc; MSc1*, Vitoria Meyer Cantinho Pereira, BSc; MSc1*, Maria A V Marzolini3*, Leigh Wood, BA4*, Joanna Olejnik5*, Yenting Ngai, PhD6*, Bilyana Popova, MSc7*, William Wilson5*, Victoria Spanswick3*, Helen Lowe1*, Leah Ensell8*, John A. Hartley, PhD3*, Farzin Farzaneh9*, Mark W. Lowdell, BSc, MSc, PhD, FRCPath10*, David C. Linch11*, Martin Pule, MD, PhD12* and Karl S Peggs, MD, PhD13*

1UCL Cancer Institute, University College London, London, United Kingdom
2Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
3UCL Cancer Institute, London, United Kingdom
4University College Hospital London, london, United Kingdom
5UCL Cancer Trials Centre, London, United Kingdom
6UCL CRUK Cancer Trials Centre, University College London, London, United Kingdom
7CRUK UCL Cancer Trials Centre, UCL, London, United Kingdom
8UCL ECMC GCLP Laboratory, University College London, London, United Kingdom
9King's College London, London, GBR
10Haematology, University College London, London, United Kingdom
11University College London, London, United Kingdom
12Cancer Institute, University College London, London, United Kingdom
13University College London Cancer Institute, UCL Cancer Institute, London, United Kingdom

Valeria Ceolin1,2*, Erica Brivio, MD2,3*, Susan R. Rheingold4, Allison Barz Leahy, MD5*, Britta Julia Vormoor6*, Maureen M. O'Brien, MD7, Jeremy Rubinstein8*, Krzysztof Kalwak9*, Barbara De Moerloose10*, Elad Jacoby11, Peter Bader12, José L. Fuster13*, Franco Locatelli, MD, PhD14, Peter Hoogerbrugge2, Friso Calkoen2* and Christian M. Zwaan2,3

1Department of Pediatric Oncology/Hematology, Regina Margherita Children's Hospital, University of Turin, Turin, Italy
2Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
3Erasmus University MC-Sophia Children’s Hospital, Rotterdam, Netherlands
4Division of Pediatric Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
5Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
6Princess Maxima Center for Paediatric Oncology, Utrecht, Netherlands
7Cincinnati Children's Hospital Medical Center, Cincinnati, OH
8Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH
9Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
10Department of Pediatric Oncology/Hematology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
11Division of Pediatric Hematology, Oncology and BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel
12Department of Pediatric Oncology/Hematology, Clinic for Children and Youth Medicine, University Hospital Frankfurt, Goethe University, Frankfurt, Germany
13Pediatric Hematology Unit, Hematology Department, Hospital de Valdecilla, Santander, Spain
14Department of Hematology/Oncology and Cell and Gene Therapy, Bambino Gesù Children’s Hospital, Sapienza, University of Rome, Rome, Italy

Jennifer A. Foltz, PhD1, Melissa M. Berrien-Elliott, PhD2, David A. Russler-Germain, MD, PhD2, Carly C. Neal2*, Jennifer Tran2*, Margery Gang, MD2*, Pamela Wong2, Matthew Mosior3*, Jeffrey J. Bednarski, MD, PhD4, Clare Zimmerman, MD4*, Celia C. Cubitt2*, Nancy D. Marin, PhD2*, Alice Y. Zhou, MD, PhD2*, Miriam T. Jacobs, MD5, Mark Foster2*, Timothy Schappe2*, Ethan McClain2*, Sweta Desai2*, Patrick Pence2*, Michelle Becker-Hapak2*, Lynne Marsala2*, Obi L. Griffith, PhD2*, Malachi Griffith, PhD2*, Saad M. Khan, PhD3*, Bryan Fisk2*, Amanda F. Cashen, MD6, Allegra A. Petti, PhD3* and Todd A. Fehniger, MD, PhD2

1Department of Medicine, Washington University School of Medicine,, Saint Louis, MO
2Department of Medicine, Washington University School of Medicine, St. Louis, MO
3Washington University School of Medicine, St. Louis, MO
4Department of Pediatrics, Washington University School of Medicine, St. Louis, MO
5Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
6Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Jay Y. Spiegel, MD, FRCPC1, Michael D. Jain, MD, PhD2, Loretta Nastoupil, MD3, John Tamaresis, PhD4*, Armin Ghobadi, MD5, Yi Lin6, Lazaros J. Lekakis, MD7*, Patrick M. Reagan, MD8, Olalekan O. Oluwole, MBBS, MPH9, Joseph P. McGuirk, DO10, Abhinav Deol11, Alison R. Sehgal, MD12, Andre H. Goy, MD13*, Brian T. Hill, MD14, Charalambos Andreadis, MD, MS15, Javier Muñoz, MD, MS, MBA, FACP16, Matthew L. Ulrickson, MD17, Jason R. Westin, MD18, Julio C. Chavez, MD, MS19*, Miriam T. Jacobs, MD20, N Nora Bennani, MD21, Aaron P. Rapoport, MD22, Julie M. Vose, MD, MBA23, David B. Miklos, MD, PhD24, Sattva S. Neelapu, MD25, Frederick L. Locke, MD2, Saurabh Dahiya, MD22 and Matthew A. Lunning, DO, FACP23

1Miller School of Medicine, University of Miami, Miami, FL
2Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Biomedical Data Science, Stanford University, Palo Alto, CA
5Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
6Mayo Clinic, Mayo Clinic, Rochester, MN
7Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
8Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
9Vanderbilt University Medical Center, Nashville, TN
10Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwoon, KS
11Karmanos Cancer Institute, Wayne State University, Detroit, MI
12UPMC Hillman Cancer Center, Pittsburgh, PA
13Division of Lymphoma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
14Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
15Department of Hematology and Blood and Marrow Transplant, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
16Mayo Clinic Arizona, Phoenix, AZ
17Banner MD Anderson Cancer Center, Gilbert, AZ
18Department of Lymphoma and Myeloma, MD Anderson, Houston, TX
19Moffitt Cancer Center, Tampa, FL
20Department of Oncology, Washington University in St. Louis, St Louis, MO
21Division of Hematology, Mayo Clinic, Rochester, MN
22Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
23Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
24Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Hospital, Stanford, CA
25Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX

Uday Prakash Kulkarni, MD*, Arun Kumar Arunachalam, MD*, Hamenth Kumar Palani, MSc, PhD*, Nithya Balasundaram, MSc*, Arvind Venkatraman, M.Tech*, Anu Korula, MD, DM*, Anup J Devasia, MD, DM*, Fouzia NA, DNB, DM*, Sushil Selvarajan, MBBS, MD, DM*, Sharon Lionel, MBBS, MD, DM*, Madhavi Maddali, MD*, Aby Abraham, MD, DM*, Poonkuzhali Balasubramanian, MSc, PhD, Biju George, MD, DM and Vikram Mathews, MD

Department of Haematology, Christian Medical College, Vellore, India

Xian Zhang1,2, Gailing Zhang, MD.2*, Wenqian Li2*, Yang Zhang, MD2, Tong Wang2*, Junfang Yang1,2*, Jingjing Li1,2* and Peihua Lu, MD1,2,3

1Beijing Lu Daopei Institute of Hematology, Beijing, China
2Hebei Yanda Lu Daopei Hospital, Langfang, China
3Department of Oncology, Capital Medical University, Beijing, China

Mingzhi Zhang, MD1*, Xiaorui Fu2*, Huimin Meng3*, Min Wang3*, Yu Wang4*, Lei Zhang5*, Ling Li6*, Xin Li5*, Xinhua Wang5*, Zhenchang Sun, M.D., Ph.D6*, Hui Yu, MD, PhD5*, Zhaoming Li5*, Feifei Nan5*, Yu Chang7*, Zhiyuan Zhou5*, Jiaqin Yan5*, Jiwei Li5*, Xiaolong Wu5*, Guifang Pan4*, Yanmei Zhao4*, Yu-Sheng Chen8*, Fengtao You8* and Lin Yang, PhD4

1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
3PersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou, China
4PersonGen BioTherapeutics (Suzhou) Co., Ltd., suzhou, China
5The First Affiliated Hospital of Zhengzhou University, zhengzhou, China
6Department of Oncology, the First Affiliated Hospital of Zhengzhou University, zhengzhou, China
7The first affiliated hospital of Zhengzhou University, zhengzhou, China
8PersonGen BioTherapeutics (Suzhou) Co., Ltd.,, suzhou, China

Mingzhi Zhang, MD1, Xiaorui Fu1*, Huimin Meng2*, Min Wang3*, Yu Wang4*, Guifang Pan5*, Lei Zhang6*, Ling Li6*, Xin Li6*, Xinhua Wang6*, Zhenchang Sun, M.D., Ph.D1*, Hui Yu, MD, PhD1*, Zhaoming Li6*, Feifei Nan6*, Yu Chang6*, Zhiyuan Zhou6*, Jiaqin Yan6*, Jiwei Li6*, Xiaolong Wu7*, Yanmei Zhao4*, Yu-Sheng Chen4*, Fengtao You3*, Dan Chen3*, Tingting Zhang3*, Bozhen Zhang3,4* and Lin Yang, PhD2,3,4

1Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China
3PersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou, China
4PersonGen-Anke Cellular Therapeutics Co., Ltd., Hefei, China
5PersonGen BioTherapeutics (Suzhou) Co., Ltd., suzhou, China
6Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
7Department of Oncology, Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Nobuhiro Nishio, MD, PhD1,2*, Ryo Hanajiri, MD, PhD3*, Yuichi Ishikawa, MD, PhD3, Makoto Murata, MD, PhD3, Rieko Taniguchi, MD1*, Motoharu Hamada1*, Eri Nishikawa, MD, PhD1*, Nozomu Kawashima, MD, PhD1*, Atsushi Narita, MD, PhD1*, Hideki Muramatsu, MD, PhD1 and Yoshiyuki Takahashi, MD, PhD1*

1Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
2Center for Advanced Medicine and Clinical Research, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan
3Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Matthew J. Frigault, MD1, Jacalyn Rosenblatt, MD2, Noopur S. Raje, MD3, Gabriel Depinho, B.S.4*, Daniella Cook, BS5*, Emma K. Logan2*, Christopher R. Heery, MD6, Christine Cornwell6*, Melissa Sheppard7*, David Avigan, MD2, Andrzej Jakubowiak8 and Michael R. Bishop, MD9

1HCTCT, Mass General Hospital Cancer Center, Boston, MA
2Beth Israel Deaconess Medical Center, Boston, MA
3Division of Hematology and Oncology, Mass General Hospital Cancer Center, Boston, MA
4Massachusetts General Hospital, Boston, MA
5Cancer Center, Massachusetts General Hospital, Boston, MA
6Arcellx, Inc., Gaithersburg, MD
7Department of Medicine, Section of Hematology and Oncology, University of Chicago Medical Center, Chicago, IL
8University of Chicago, Chicago, IL
9The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL

Paolo F. Caimi, MD1,2, Armin Ghobadi, MD3, Jane Reese4*, Benjamin Tomlinson, MD5, Folashade Otegbeye, MBBChir, MPH6, Julie K Ritchey7*, Tabatha Trummer8*, Jennifer Schiavone8*, Kayla Zamborsky8*, Linda G Eissenberg, PhD7*, Julia Hollaway7*, Dina Schneider, PhD9, Kristen Bakalarz, CNP10*, Kirsten M Boughan, DO5, Leland Metheny III, MD5, Seema Patel, PharmD11*, Erin Galloway, RN BSN10*, Molly Gallogly, MD, PhD5, Winfried Krueger, PhD12*, Michael Kadan13*, Gabriela Pacheco Sanchez14*, Ashish Sharma14*, David Wald, MD, PhD4*, Brenda W. Cooper, MD10, John F. DiPersio, MD, PhD15, Rafick Sekaly14*, Rimas J Orentas, PhD16, Boro Dropulic, PhD, MBA17* and Marcos J.G. de Lima, MD18

1Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Cleveland Clinic Lerner College of Medicine, Case Comprehensive Cancer Center, Cleveland, OH
3Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
4Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
5Case Western Reserve University, Cleveland, OH
6Case Western Reserve University, Cleveland, OH, USA, Cleveland, OH
7Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
8University Hospitals Seidman Cancer Center, Cleveland, OH
9Lentigen Technology, Gaithersburg, MD
10Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
11Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
12Lentigen Technology, Inc., a Miltenyi Biotec Company, Gaithersburg, MD
13Lentigen Technology Inc., A Miltenyi Biotec Company, Gaithersburg, MD
14Emory University, Atlanta, GA
15Division of Oncology, Washington University School of Medicine, Saint Louis, MO
16Pediatrics, University of Washington School of Medicine, Seattle, WA
17Caring Cross, Gaithersburg, MD
18Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Sang A Kim, MD1*, Youngil Koh, MD, PhD2, Miyoung Jung3*, Yu Kyeong Hwang3*, Ja Min Byun2*, Junshik Hong, MD2, Dong-Yeop Shin, MD, PhD2*, Inho Kim, MD, PhD2* and Sung-Soo Yoon, MD2

1Department of Internal medicine, Seoul National University Bundang Hospital, Seoul, South Korea
2Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
3Cell Therapy Research Center, GC LabCell, Yongin, Korea, Republic of (South)

Andreas Mackensen, MD1*, Linda Hanssens2*, Matthias Stelljes, MD3, Wolfgang A Bethge4*, Tobias Feuchtinger, MD5, Annette Künkele, MD6*, Michael Aigner, PhD7*, Alisa Yakushina2*, Sandra Karitzky2*, Silke Holtkamp2*, Mario Assenmacher8*, Marion Jurk9*, Georg Rauser2*, Dina Schneider10* and Claudia Rossig, Prof., MD11

1Department of Medicine 5 - Hematology and Oncology, Friedrich-Alexander University, Erlangen-Nuernberg, Erlangen, Germany
2Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany
3Universitätsklinikum Münster, Münster, Germany
4Universitaets Klinikum Tuebingen, Tuebingen, DEU
5Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University, Munich, Germany
6charite Hospital, Berlin, Germany
7University of Erlangen-Nuernberg - Hematology/Oncology, Erlangen, Germany
8Miltenyi Biotec B.V. & Co. KG, Bergisch Galdbach, NRW, Germany
9Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
10A Miltenyi Biotec Company, Lentigen Technology Inc., Gaithersburg, MD
11University Children's Hospital Muenster, Muenster, Germany

Lekha Mikkilineni, MD1, Elisabet E. Manasanch, MD2, Danielle Natrakul3*, Jennifer N. Brudno, MD3, Jennifer Mann, CRNP3*, Stephanie L Goff, MD3*, James C Yang, MD4*, Norris Lam, BS3*, Irina Maric, MD, MSci5, Maryalice Stetler-Stevenson, MD, PhD6*, Hao-Wei Wang, MD, PhD7, Constance M. Yuan, MD, PhD6*, Tyler Lowe8*, David F. Stroncek, MD9, Steven Highfill, PhD10*, Rashmika Patel11*, Micaela Ganadan, BSN, RN3*, Steven A Rosenberg, MD, PhD12* and James N. Kochenderfer, MD13

1Surgery Branch, National Cancer Institute, Washington, DC
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Surgery Branch, National Cancer Institute, Bethesda, MD
4Surgery Branch, National Cancer Institute, Maryland
5Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
6Laboratory of Pathology, National Cancer Institute, Bethesda, MD
7Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
8Department of Laboratory Pathology, National Cancer Institute, Bethesda, MD
9Center for Cellular Engineering, National Institutes of Health, Bethesda, MD
10Center for Cellular Engineering, National Institute of Health, Bethesda, MD
11Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda
12Surgery Branch, National Cancer Institute, Bethesda
13Surgery Branch, NCI, Bethesda, MD

Yan Asmann, PhD1, Ying Li, Ph.D.2*, Taxiarchis Kourelis, M.D.3, Moritz Binder, MD, MPH3*, Wilson I Gonsalves, MD3, Henan Zhang, M.D.3*, Anatilde Gonzalez Guerrico, PhD3*, Zuoyi Shao, Ph.D.2*, Prashant Kapoor, MD3, David Dingli, M.D., Ph.D.3, Rahma M Warsame, MD3, Haidong Dong, MD PhD3*, Shaji K Kumar, MD4 and Yi Lin4

1Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL
2Division of Hematology, Mayo Clinic Rochester, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester, MN

Jessica S. Little, MD1,2,3*, Parth Shah, MD1,2, Adam S. Sperling, MD, PhD1,2, Andrew R. Branagan, MD, PhD1,4, Omar Nadeem, MD1,2, Andrew J. Yee, MD1,5, Noopur S. Raje, MD1,5, Nikhil C. Munshi, MD, PhD1,2 and Sarah Hammond, MD1,2,5,6*

1Harvard Medical School, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA
4Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA
5Massachusetts General Hospital Cancer Center, Boston, MA
6Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA

Sumaira Zareef, MD1*, Astha Thakkar, MBBS2, Ryann Quinn, MD3*, An Tran4*, Alyssa De Castro, PharmD5*, Jennat Mustafa, PA-C6*, Fariha Khatun, PA-C6*, Amanda Lombardo, PA-C, BS, MS6*, Latoya Townsend Nugent, NP4*, Richard Elkind, PA-C, MS6, Kira Gritsman, MD, PhD7, Mendel Goldfinger, MD8, Noah Kornblum, MD6*, Aditi Shastri, MD9, Ioannis Mantzaris, MD, MS8, Lizamarie Bachier Rodriguez, MD1, Lili Zhang10*, Amit Verma, MD11, Ira Braunschweig, MD8 and R. Alejandro Sica, MD12*

1Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
2Oncology, Montefiore Medical Center, New York, NY
3Montefiore Medical Center, Bronx, NY
4Montefiore Medical Center, Bronx
5Department of Pharmacy, Montefiore Medical Center, Bronx, NY
6Department of Oncology, Montefiore Medical Center, Bronx, NY
7Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
8Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
9Division of Hematologic Malignancies, Department of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
10Cardiology, Montefiore Medical Center, Bronx
11Department of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
12Department of Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Arushi Khurana, MBBS1, Matthew Hathcock1*, Radhika Bansal, MBBS1*, Yucai Wang, MD, PhD1, Jonas Paludo, MD1, Jose C. Villasboas, MD1, N. Nora Bennani, M.D.1, Patrick B. Johnston, M.D., Ph.D.1, Stephen M. Ansell, MD, PhD1 and Yi Lin2

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN

Arushi Khurana, MBBS1, Radhika Bansal, MBBS1*, Matthew Hathcock1*, Adrienne Nedved, Pharm.D., R, Ph1*, Yucai Wang, MD, PhD1, Jonas Paludo, MD1, Jose C Villasboas1*, N. Nora Bennani, M.D.1, Patrick B. Johnston, M.D., Ph.D.1, Stephen M. Ansell, MD, PhD1 and Yi Lin2

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN

Wenbin Qian, MD, PhD1*, Aiqi Zhao, MD, PhD2*, Hui Liu, MD, PhD1*, Wen Lei, MD, PhD1*, Yun Liang, MD, PhD1* and Xianggui Yuan1*

1Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
2Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, AL, China

Bijal D. Shah, MD1, Imi Faghmous2*, James Whitmore, PhD2*, Behzad Kharabi Masouleh, MD3* and Hairong Xu, MD, PhD3*

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Kite, A Gilead Company, Santa Monica, CA
3Kite, a Gilead Company, Santa Monica, CA

Jeremy S. Abramson, MD1, Scott R. Solomon, MD2, Jon E. Arnason, MD3, Patrick B. Johnston, M.D., Ph.D.4, Bertram Glass, MD5*, Alessandro Crotta, MD6*, Sandrine Montheard, MS7*, Alessandro Previtali, MSc6*, Fei Fei Liu, BSc, MBA8*, Julia Braverman, PhD8*, Shien Guo, PhD9*, Ling Shi, PhD9* and Manali Kamdar, MD10

1Lymphoma Program, Massachusetts General Hospital Cancer Center, Boston, MA
2Leukemia Program, Northside Hospital Cancer Center Institute, Atlanta, GA
3Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
4Division of Hematology, Mayo Clinic, Rochester, MN
5Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany
6Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
7Celgene, a Bristol-Myers Squibb Company,, Boudry, Switzerland
8Bristol Myers Squibb, Princeton, NJ
9Clinical Outcomes Assessment, Evidera, Waltham, MA
10Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO

Javier Pinilla Ibarz, MD, PhD1, Meixiao Long, MD2, John Lister, MD3, Jennifer A. Woyach, MD4, Friedrich Graf Finckenstein, MD5*, Madan Jagasia, MD, MS, MMHC5*, Selda Samakoglu, MD, PhD5*, Bhagyashree Yadav, MD5*, Huiling Li, PhD5* and John C. Byrd, MD6

1H. Lee Moffitt Cancer Center, Tampa, FL
2Division of Hematology, Department of Internal Medicine, Ohio State University Hospital, Columbus, OH
3Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
4The Ohio State University, Columbus, OH
5Iovance Biotherapeutics, Inc., San Carlos, CA
6Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH

Sairah Ahmed, MD1, Ian W. Flinn, MD, PhD2, Matthew Mei, MD3, Peter A. Riedell, MD4, Philippe Armand, MD, PhD5, Natalie S Grover, MD6, Andreas Engert, MD7, Natalia Lapteva, PhD8*, Paul I. Nadler, MD9, Aung Myo, MD10* and Helen E. Heslop, MD, DSc11

1Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
2Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
3Division of Lymphoma, City of Hope Medical Center, Duarte, CA
4Section of Hematology/Oncology, University of Chicago, Chicago, IL
5Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, MA
6Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
7Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
8Department of Pathology and Immunology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
9Nadler Pharma Associates, Randolph, NJ
10Clinical Development, Tessa Therapeutics, Singapore, Singapore
11Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX

Xingyu Cao1,2*, Guangna Liu, PhD3*, Jianping Zhang1,2*, Yanli Zhao, MD1,4*, Hua Chen3*, Hongli Zheng5*, Wei Rui5*, Lemei Jia3*, Xueqiang Zhao5*, Xin Lin3* and Peihua Lu, MD1,6

1Beijing Lu Daopei Institute of Hematology, Beijing, China
2Department of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China
3Department of Basic Medical Sciences and Institute for Immunology, Tsinghua University School of Medicine, Beijing, China
4Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China
5China Immunotech (Beijing) Biotechnology Co. Ltd., Beijing, China
6Hebei Yanda Lu Daopei Hospital, Langfang, China

Irene Scarfò, PhD1, Kathleen M.E. Gallagher, PhD2*, Mark B. Leick, MD3*, Michael C. Kann4*, Justin Budka, PhD5*, Bharat Sowrirajan, PhD5*, Kim Nguyen, PhD5*, Rhine R. Shen, PhD5*, Adrian Bot, MD, PhD5* and Marcela V. Maus, MD6

1Massachusetts General Hospital, Charlestown, MA
2Massachusetts General Hospital, Harvard Medical School, Charlestown, MA
3Cellular Immunotherapy Program, Massachusetts General Hospital, boston, MA
4Massachusetts General Hospital, Boston, MA
5Kite, a Gilead Company, Santa Monica, CA
6Cancer Center, Massachusetts General Hospital, Boston, MA

Mariana Bastos-Oreiro, MD, PhD1,2*, Antonio Gutierrez, MD, PhD3*, Juan Luis Reguera4*, Gloria Iacoboni, MD5*, Lucía López Corral, MD6*, María José Terol, MD PhD7*, Valentín Ortiz-Maldonado, MD, PhD8*, Jaime Sanz9*, Luisa Maria Guerra, MD10*, Alberto Mussetti, MD11*, Pau Abrisqueta Costa, MD, PhD12*, Javier Delgado Serrano, MD13*, Rafael Hernani, MD14*, Hugo Daniel Luzardo Henriquez15*, Juan-Manuel Sancho16*, Carlos Montalban, MD, PhD17*, Antonio Salar, MD, PhD18*, Carlos Grande19*, Leyre Bento, MD, PhD20*, Sonia González de Villambrosia, MD21*, Daniel Garcia22*, Blanca Herrero23*, Nuria Martínez-Cibrian, MD24*, Anna Sureda25, Antonio Perez-Martinez, MD, PhD26*, Pere Barba, MD, PhD27*, Mi Kwon, MD, PhD28,29* and Alejandro Martin Garcia-Sancho30*

1Hematology department, Gregorio Marañón General University Hospital (HGUGM), Madrid, Spain
2Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain
3Department of Hematology, Hospital Universitario Son de Espases, Palma, Spain
4Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla, Spain
5Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain
6Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
7Department of Hematology, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, Spain
8Department of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain
9Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Valencia, Spain
10Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain
11Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, Barcelona, Spain
12Hospital Vall d'Hebron, Barcelona, ESP
13hematology department, University Hospital Virgen del Rocío. Institute of Biomedicine of Seville (IBiS / CSIC / CIBERONC), University of Seville, Seville, Spain., Madrid, Spain
14Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
15Hematology Department, Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain
16Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Spain
17Hematology, MD Anderson Cancer Center, Madrid, Spain
18Department of Haematology, Hospital del Mar-IMIM, Barcelona, Spain
19Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
20Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain
21Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
22Hematology Department, Hospital Sanitas La Zarzuela, Madrid, Spain
23Pediatric onco-hematology department, Hospital Universitario niño Jesús, Madrid, Spain
24Department of Hematology, University Hospital Virgen del Rocio, Sevilla, Spain
25Clinical Hematology Department, Institut Català d'Oncologia, Hospitalet, Hospital Duran i Reynals, Hematology Department, Institut Català d'Oncologia - Hospitalet, Barcelona, Spain
26Department of Hematologia-Oncologia, Hospital Universitario La Paz, Madrid, Spain
27Department of Hematology, Vall d’Hebron University Hospital, University Hospital Vall d’Hebron, Barcelona, Spain
28Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain
29Hematology Department, Gregorio Marañón General University Hospital, Madrid, Spain
30Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain

Audrey M. Sigmund, MD1, Nathan Denlinger, MS, DO1, Amneet Bajwa, MD, MBA2*, Patrick Elder, MS1*, David A. Bond, MD, BS1, Jonathan E Brammer, MD1, Ayman Saad, MD1, Sam Penza, MD1, Marcos J.G. de Lima, MD1, Samantha Jaglowski, MD1 and Adam S Kittai, MD1

1Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
2Division of Hospital Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH

Kai Rejeski, MD1, Ariel Perez-Perez, MD2*, Gloria Iacoboni, MD3*, Olaf Penack, MD4*, Veit L Buecklein, MD1*, Liv Jentzsch5*, Dimitrios Mougiakakos, MD6*, Grace Johnson7*, Brian Arciola7*, Viktoria Blumenberg, MD1, Cecilia Carpio, MD3*, Eva Hoster, PhD1*, Lars Bullinger8, Frederick L. Locke, MD9, Michael von Bergwelt, MD, PhD1*, Andreas Mackensen, MD6*, Wolfgang A Bethge5*, Pere Barba, MD, PhD10*, Michael D. Jain, M.D., Ph.D.9 and Marion Subklewe, MD11

1Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
2Blood & Marrow Transplant Program, Miami Cancer Institute, Miami, FL
3Department of Hematology, University Hospital Vall d’Hebron, Barcelona, Spain
4Department of Hematology, Oncology and Tumorimmunology, Charité University Hospital, Campus Virchow Clinic, Berlin, Germany
5Department of Hematology, Oncology, Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany
6Department of Internal Medicine 5, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany
7USF Morsani College of Medicine, Tampa, FL
8Department of Hematology, Oncology and Tumorimmunology, Charite University Berlin, Berlin, Germany
9Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
10Hospital Universitari Vall d’Hebron and Universitat Autonoma de Barcelona, Barcelona, Spain
11Department of Medicine III, University Hospital, LMU Munich, Muenchen, Germany

Jieqi Liu, MD1, Epperla Narendranath, MD2*, Armin Ghobadi, MD3, Aleksandr Lazaryan, MD4, Uroosa Ibrahim, MD, MBBS5*, Caron Jacobson, MD6, Seema G Naik, MD7*, Adam J. Olszewski, MD8, Yong Lin, PhD9*, Sayan Mullick Chowdhury, DO, PhD2*, Miriam T. Jacobs, MD3, Loretta Nastoupil, MD10, Keren Osman, MD5*, Sairah Ahmed, MD11 and Andrew M. Evens, DO, MMSc9

1Rutgers Cancer Institute of New Jersey, Hoboken, NJ
2Ohio State University Medical Center, Columbus, OH
3Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
4Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
5Department of Hematology and Oncology, Bone Marrow Transplantation and Cellular Therapy Program, Mount Sinai Hospital, New York, NY
6Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
7Penn State Cancer Institute, Penn State Hershey Medical Center, Hershey, PA
8Lifespan Cancer Institute, Alpert Medical School of Brown University, Providence, RI
9Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
10Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX

Veronika Bachanova, MD, PhD1, Joseph E. Maakaron, MD2, Frank Cichocki3*, David H. McKenna, MD4, Qing Cao, MS5*, Todd E. DeFor, MS5*, Murali Janakiram, MD6, Rose Wangen2*, Zuzan Cayci, MD7*, Bartosz Grzywacz, MD4, Ronit Simantov8*, Tracey Lodie, PhD9* and Jeffrey S. Miller, MD3

1Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
2Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
3University of Minnesota, Minneapolis, MN
4Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN
5Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
6Division of Hematology, Oncology and Transplantation, University of Minnesota, Mpls, MN
7Department of Radiology, University of Minnesota, Minneapolis, MN
8Gamida, Boston, MA
9Gamida Cell, Boston, MA

Ariel Perez Perez, MD1, Grace Johnson2*, Kedar Patel3*, Brian Arciola2*, Anthony Wood, MD4*, Christina A Bachmeier, PharmD5*, Julio C. Chavez, MD6, Bijal D. Shah, MD7, Farhad Khimani, MBBS8, Taiga Nishihori, MD9, Aleksandr Lazaryan, MD5, Marco L. Davila, MD, PhD5, Rahul Mhaskar, MPH10*, Frederick L. Locke, MD5, Sameh Gaballa, MD7 and Michael D. Jain, M.D., Ph.D.5

1Blood and Marrow Transplant Program, Miami Cancer Institute, Miami, FL
2USF Morsani College of Medicine, Tampa, FL
3USF Morsani College of Medicine, Tampa
4H. Lee Moffitt Cancer & Research Center, Tampa, FL
5Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
6Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
7H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
9H. Lee Moffitt Cancer Center, Tampa, FL
10University of South Florida, Tampa, FL

Radhika Bansal, MBBS1*, Anatilde Gonzalez Guerrico, PhD1*, Henan Zhang, M.D.1*, Zuoyi Shao, PhD1*, Elham Babadi, MD1*, Kodi E Marinez1*, Gabrielle Gonzalez McCoy1*, Matthew A Hathcock1*, Arushi Khurana, M.B.B.S.1*, N. Nora Bennani, M.D.1, Jonas Paludo, MD1, Yucai Wang, MD, PhD1, Stephen M. Ansell, MD, PhD1, Patrick B. Johnston, M.D., Ph.D.1, Jose C Villasboas1* and Yi Lin2

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN

Radhika Bansal, MBBS1*, Paschalis Vergidis, MD2*, Pritish K Tosh, MD2*, John Wilson, MD2*, Matthew Hathcock1*, Arushi Khurana, MBBS1, N. Nora Bennani, M.D.1, Jonas Paludo, MD1, Jose C. Villasboas, MD1, Yucai Wang, MD, PhD1, Stephen M. Ansell, MD, PhD1, Patrick B. Johnston, M.D., Ph.D.1, Catherine Freeman, MD3* and Yi Lin4

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Infectious Diseases, Mayo Clinic, Rochester, MN
3Division of Asthma, Allergy and Clinical Immunology, Mayo Clinic, Scottsdale, AZ
4Mayo Clinic, Rochester, MN

Caitlin Costello, MD1, Ben A Derman, MD2, Mehmet Hakan Kocoglu, MD3, Abhinav Deol4, Abbas Abbas Ali, MD5, Tara Gregory, MD6*, Bhagirathbhai Dholaria, MBBS7, Jesus G Berdeja, MD8*, Adam D Cohen9, Krina K. Patel, MD, MSc10, David S. Siegel, MD, PhD11, Rajneesh Nath, MD12, Katherine McArthur13*, Joanne McCaigue, M.S.13*, Christopher E Martin, PhD13*, Majid Ghoddusi, PhD, DVM13*, Hamid Namini, Ph.D.13*, Eric M. Ostertag, MD, PhD13*, Matthew A. Spear, MD13, Rajesh Belani, MD13* and Nina Shah, MD14

1UC San Diego Health, Moores Cancer Center, La Jolla, CA
2Rush University Medical Center, Chicago, IL
3Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
4Karmanos Cancer Institute, Wayne State University, Detroit, MI
5Sidney Kimmel Comprehensive Cancer Center, John's Hopkins Hospital, Baltimore, MD
6Sarah Cannon Research Institute, Denver, CO
7Vanderbilt University Medical Center, Nashville, TN
8Sarah Cannon Research Institute, Nashville, TN
9Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
10MD Anderson Cancer Center, University of Texas, Houston, TX
11Hackensack Univ. Med. Ctr., Hackensack, NJ
12Banner Health at MD Anderson Cancer Center, Scottsdale, AZ
13Poseida Therapeutics, San Diego, CA
14University of California San Francisco, San Francisco, CA

Maria Gabelli1*, Macarena Oporto Espuelas2*, Denise Bonney3*, Saskia Burridge1*, Susan Farish1*, Khushnuma Mullanfiroze, MD1*, Arina Lazareva1*, Sujith Samarasinghe4*, Philip Ancliffe4*, Ajay Vora4, Jack Bartram4*, Emma Hedges4*, Kirsty Ware4*, Lindsey Young1*, Chiara Cugno5, Lenka Chenchara5*, Juliana Silva1,6*, Oana Mirci-Danicar6*, Lynne Riley4*, Vesna Pavasovic4*, Anupama Rao4*, Paul Veys1*, Giovanna Lucchini1*, Robert Chiesa1*, Kanchan Rao1*, Persis J Amrolia, MBBS, FRCPath, PhD1,7* and Sara Ghorashian, FRCPath, PhD4,8

1Bone Marrow Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom
2Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, London, United Kingdom
3Bone Marrow Transplantation, Royal Manchester Children's Hospital, Manchester, United Kingdom
4Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
5Pediatric Oncology and Hematology, Sidra Medicine, Doha, Qatar
6Bone Marrow Transplantation, Bristol Royal Hospital for Children, Bristol, United Kingdom
7UCL Great Ormond Street Institute of Child Health, London, United Kingdom
8Developmental Biology and Cancer, UCL Great Ormond Street Institute of Child Health, London, ENG, United Kingdom

Luxin Yang1*, Yi Luo, MD2*, He Huang3, Yamin Tan, MD2*, Jimin Shi, MD2*, Yanmin Zhao2*, Jian Yu, MD2* and Xiaoyu Lai, MD2*

1the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
2Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
3Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Felix Korell1*, Olaf Penack, MD2*, Michael Schmitt, MD1, Carsten Müller-Tidow, MD1*, Lars Bullinger2, Peter Dreger, MD1 and Thomas Luft, MD, PhD1

1Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
2Department of Hematology, Oncology and Tumorimmunology, Charite University Berlin, Berlin, Germany

Liana Nikolaenko, MD1, Alex F. Herrera, MD1, Elizabeth Budde, MD, PhD2, Joo Y. Song, MD3 and Geoffrey Shouse, PhD4

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2T Cell Therapeutics Research Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3Department of Pathology, City of Hope National Medical Center, Duarte, CA
4Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA

Shrikanta Chattopadhyay, MD, Christopher Malcuit, PhD*, Ryo Takeuchi, PhD*, Emmett Hedblom, PhD*, Warren Jaworowicz*, Antoine J Boudot, Ph.D.*, Hannah Bader, Ph.D.*, James Murray* and Gavin Macbeath, PhD*

TScan Therapeutics, Waltham, MA

Adam S. Sperling, MD, PhD1, Sarah Nikiforow, MD, PhD1, Omar Nadeem, MD1, Clifton C Mo, MD1*, Jacob P. Laubach1*, Kenneth C. Anderson, MD1, Alejandro Alonso, BS1*, Shuntaro Ikegawa, MD1*, Rao Prabhala, PhD1, Diego Hernandez Rodriguez1*, Heather Daley1*, Kit L. Shaw, PhD1*, Yohei Arihara, MD, PhD1*, Soudeh Ansari2*, David S Quinn2*, David Pearson, PhD3*, Anniesha Hack, PhD4*, Louise M Treanor, PhD2*, Dexiu Bu, PhD2*, Jennifer Mataraza, PhD2*, Lawrence Rispoli2*, Marc Credi2*, Jerome Ritz, MD1, Serena De Vita, MD, PhD2 and Nikhil C. Munshi, MD, PhD1

1Dana-Farber Cancer Institute, Boston, MA
2Novartis Institutes for BioMedical Research, Cambridge, MA
3Novartis Institutes for BioMedical Research, Basel, MA, Switzerland
4Novartis Pharmaceuticals Corporation, East Hanover, NJ

Taiga Nishihori, MD1, James E. Hoffman2*, Jonathan L. Kaufman, MD3, Anne Huff4*, Charlotte Snape5*, Amit Jain4*, Gurpreet Kapoor4*, Stefan Zajic4*, Sunil Suchindran4*, Michael Chisamore6* and Aaron P. Rapoport7*

1Moffitt Cancer Center, Tampa, FL
2Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
3Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
4GlaxoSmithKline, Collegeville, PA
5Veramed, Twickenham, London, United Kingdom
6Merck & Co., Inc., Kenilworth, NJ
7University of Maryland Greenebaum Comprehensive Cancer Center and School of Medicine, Baltimore, MD

Yael C. Cohen1*, Adam D Cohen2, Michel Delforge3*, Jens Hillengass4, Hartmut Goldschmidt5,6, Katja Weisel7*, Marc-Steffen Raab8*, Christof Scheid9, Jordan M. Schecter10, Kevin C. De Braganca10*, Helen Varsos10*, Tzu-min Yeh10*, Liwei Wang10*, Martin Vogel11*, Christina Corsale11*, Muhammad Akram12*, Lida Pacaud12*, Tonia Nesheiwat12*, Mounzer Agha13 and Hermann Einsele14

1Tel-Aviv Sourasky (Ichilov) Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
2Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
3University Hospitals (UZ) Leuven, Leuven, Belgium
4Roswell Park Comprehensive Cancer Center, Buffalo, NY
5University Hospital Heidelberg, Heidelberg, Germany
6Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany
7University Medical Center Hamburg-Eppendorf, Hamburg, Germany
8University Hospital Heidelberg and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany
9University of Cologne, Cologne, Germany
10Janssen R&D, Raritan, NJ
11Janssen Global Services, LLC., Raritan, NJ
12Legend Biotech USA, Piscataway, NJ
13UPMC Hillman Cancer Center, Pittsburgh, PA
14Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Annalisa Chiappella, MD1, Anna Guidetti1,2, Anna Dodero1*, Stefania Bramanti3*, Pier Luigi Zinzani4,5, Armando Santoro3*, Beatrice Casadei4,5*, Alice Di Rocco6*, Matteo Giovanni Carrabba7*, Patrizia Chiusolo8,9*, Massimo Martino10*, Anna Maria Barbui11*, Maria Chiara Tisi12*, Riccardo Saccardi13, Vincenzo Maria Perriello14*, Enrico Orciuolo15*, Barbara Botto16*, Domenico Russo17, Rosalba Miceli18*, Silva Ljevar19*, Cristiana Carniti1* and Paolo Corradini, MD1,20,21

1Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
2Chair of Hematology, Università di Milano, Milano, Italy
3Division of Hematology and Stem Cell Transplantation, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
4Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
5IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
6Department of Translational and Precision Medicine, University "La Sapienza", Roma, Italy
7Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Hospital, Milan, Italy
8Department of Medical Imaging, Radiotherapy, Oncology and Haematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
9Hematology Section, Department of Radiology and Hematology, Università Cattolica del Sacro Cuore, Roma, Italy
10Stem Cell Transplantation and Cellular Therapies Unit, Grande Ospedale Metropolitano “Bianchi-Melacrino-Morelli”, Reggio Calabria, Italy
11Hematology Unit, Azienda Socio Sanitaria Territoriale (ASST), Ospedale Papa Giovanni XXIII, Bergamo, Italy
12Cell Therapy and Hematology, Ospedale San Bortolo, Vicenza, Italy
13Department of Cellular Therapy and Transfusion Medicine, Unit of Stem Cell Transplantation, Ospedale Universitario Careggi, Firenze, Italy
14Institute of Hematology and Centre of Haemato-Oncology Research (CREO), Ospedale e Università di Perugia, Perugia, Italy
15Hematology Division, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
16Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
17Unit of Blood Disease and Bone Marrow Transplantation and Unit of Hematology, Università di Brescia, “ASST-Spedali Civili” di Brescia, Brescia, Italy
18Unit of Clinical Epidemiology and Trial Organization; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
19Unit of Clinical Epidemiology and Trial Organization; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy
20Chair of Hematology, University of Milano Istituto Nazionale Tumori, Milano, Italy
21On behalf of Società Italiana di Ematologia, SIE, Italy, Italy

Michael Dickinson, MBBS1, Nada Hamad2, Christian E Bryant, MBBS, PhD, FRACP, FRCPA3*, Gautam Borthakur, MD4, Chitra Hosing, MD5, David Shook, MD6, Joanne Tan, PhD6*, Kanya Rajangam, MD, PhD6*, Hongtao Liu, MD, PhD7, Glen A Kennedy, MBBS, FRACP, FRCPA8*, Peter A. McSweeney, MD9* and Brian T. Hill, MD10

1Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and and the University of Melbourne, Melbourne, VIC, Australia
2Department of Haematology, St Vincent's Hospital Sydney, Australia and St Vincent's Clinical School, Sydney, University of New South Wales, Sydney, NSW, Australia
3Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
6Nkarta Therapeutics, South San Francisco, CA
7Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL
8Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
9Sarah Cannon Blood Cancer Network, Colorado Blood Cancer Institute, Denver, CO
10Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH

Nadeem Tabbara, MD1*, John Sharp, MD2*, Daria Gaut, MD3, Kevin Tang, MD4, Thanh Pham, PhD5*, Caspian Oliai, MD6, Myung Sim, PhD7*, Patricia A. Young, MD8 and Joshua Sasine, MD9

1Department of Medicine, University of California Los Angeles, Los Angeles, CA
2Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
3Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA
4Department of Medicine, Baylor College of Medicine, El Monte, CA
5Molecular, Cellular, and Integrative Physiology, University of California Los Angeles, Los Angeles, CA
6Department of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA
7Department of Medicine Statistics Core, Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, CA
8Division of Hematology and Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA
9Department of Medicine, Division of Hematology and Cellular Therapy, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA

Ajlan Al Zaki, MD1, Jason R. Westin, MD2, Grace Watson3*, Lei Feng, MS4*, Sairah Ahmed, MD5, Haleigh Mistry6*, Loretta Nastoupil, MD7, Misha Hawkins8*, Ranjit Nair, MD9, Swaminathan P Iyer, MD10, Hun Lee, MD7*, Raphael E Steiner, MD11, Christopher R. Flowers12, Elizabeth J Shpall, MD13, Partow Kebriaei, MD13, Sattva S. Neelapu, MD14 and Paolo Strati, MD11

1MD Anderson Cancer, Houston, TX
2Department of Lymphoma and Myeloma, MD Anderson, Houston, TX
31400 Holcombe Blvd, MD Anderson Cancer Center, Houston, TX
4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
5MD Anderson Cancer Center, Houston, TX
6MD Anderson Cancer Center:, Houston, TX
7Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
9Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
10Department of Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
11Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
12Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
13Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
14Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX

Linde Dekker, MSc1*, Friso Calkoen2*, Yilin Jiang, MSc1*, Hilly Blok, BASc1*, Maike Spoon, MSc1*, Rick Admiraal, MD, PhD1*, Peter Hoogerbrugge1, Britta Julia Vormoor1*, Josef Vormoor, Prof, MD, PhD1, C. Michel Zwaan, Prof, MD, PhD3*, Henk Visscher, MD, PhD1*, Marc Bierings, MD, PhD1, Marieke Van Der Vlugt, MSc1*, Harm Van Tinteren1*, A. Laura Nijstad, MSc4*, Kim Van Der Elst, PhD4*, Alwin D. R. Huitema1,4,5*, Rob Pieters, Prof, MD, PhD1, Caroline Lindemans, MD, PhD1* and Stefan Nierkens, PhD1,4*

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Princess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands
3Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
4University Medical Center Utrecht, Utrecht, Netherlands
5The Netherlands Cancer Institute, Amsterdam, Netherlands

Mazyar Shadman, MD1,2,3, Cecilia Yeung, MD2, Mary Redman, PhD2*, Sang Yun Lee, Ph.D.4*, Dong Hoon Lee, B.S.4*, Susan Ra, BS2*, Chaitra S. Ujjani, MD1, Bruce J. Dezube, MD5*, Christina Poh, MD6, Edus H. Warren, MD, PhD1, Aude G. Chapuis, MD2, Damian J. Green, MD2,7, Andrew J. Cowan, MD2,8, Ryan D. Cassaday, MD9,10, Hans-Peter Kiem, MD PhD2,11, Jordan Gauthier, MD12,13, Cameron J. Turtle, MBBS, PhD7,12, Ryan C. Lynch, MD14, Stephen D. Smith, MD8,15, Ajay K Gopal, MD1,16, David G. Maloney, MD, PhD17 and Brian G. Till, MD8,16

1University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
2Fred Hutchinson Cancer Research Center, Seattle, WA
3Division of Medical Oncology, Uw/Fred Hutchinson Cancer Research Center, Seattle, WA
4Fred Hutchinson Cancer Research Center, Seattle
5Mustang Bio, Worcester, MA
6Division of Medical Oncology, University of Washington, Seattle, WA
7Department of Medicine, University of Washington, Seattle, WA
8Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
9UW/FHCRC, Seattle, WA
10Department of Medicine, Division of Hematology, University of Washington, Seattle, WA
11University of Washington, Seattle, WA
12Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA
13University of Washington, Seattle Cancer Care Alliance, Seattle, WA
14Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA
15Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
16University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
17Fred Hutchinson Cancer Rsrch. Ctr., Seattle, WA

Krish Patel, MD1, Veronika Bachanova, MD, PhD2, Aaron M Goodman3, John M. Pagel, MD, PhD4, Kelly Griffis5*, Marlisa Anderson, MPH5*, Siminder Atwal, PhD5*, Cara Bickers, PhD5*, Peter Szabo, MD, PhD5*, Lilly Wong, PhD5*, Yu-Waye Chu, MD5, Rebecca Elstrom, MD5 and Paolo Strati, MD6

1Swedish Cancer Institute, Seattle, WA
2Masonic Cancer Center, University of Minnesota, Minneapolis, MN
3UCSD Moores Cancer Center, La Jolla, CA
4Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
5Fate Therapeutics, Inc., San Diego, CA
6The University of Texas MD Anderson Cancer Center, Houston, TX

Kirubel Gebre1*, Bradley Drumheller, MD, BS2*, Sophia Faude3*, Jane Wei4*, Jared McFerran4* and Vinodh Pillai, MD, PhD5,6

1University of Pennsylvania Perelman School of Medicine, Lancaster, PA
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
3Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
4University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
5Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
6Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA

Tapan M. Kadia, MD1, Naveen Pemmaraju, MD2, Musa Yilmaz, MD2, Naval Daver, MD3, Li Li, M.D.4*, Mi-Ae Lyu, Ph.D.4*, Meixian Huang, M.D., Ph.D.4*, Ke Zeng, M.D.4, Robin Cook, RN2*, Simrit Parmar, MBBS5, Siddhartha Mukherjee, MD, PhD6*, Tara Sadeghi7*, Courtney D. DiNardo, MD, MSCE2, Ghayas C. Issa, MD2, Elias J. Jabbour8, Gautam Borthakur, MD9, Nitin Jain, MD10 and Srdan Verstovsek, MD, PhD1

1Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
6Myelodysplastic Syndrome Center, Columbia University Medical Center, New York, NY
7Cellenkos Inc., Houston, TX
8Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
9MD Anderson Cancer Center, The University of Texas, Houston, TX
10Department of Leukemia, MD Anderson Cancer Center, Houston, TX

Forat Lutfi, MD1, Olga Goloubeva, PhD, MSc2*, Dong Won Kim, MD2*, Amer Kowatli, MD3*, Anton Gryaznov, MD3*, Philip Margiotta, MD4, Lisa R Matsumoto, BS5*, David Gottlieb, MD1*, Ali Bukhari, MD1, Caroline Dunne, MD5*, Jennie Y. Law, MD6, Seung-Tae Lee, MD, PhD7*, Kathleen Ruehle, RN2*, Jean A. Yared, MD8, Mehmet Hakan Kocoglu, MD1, Djordje Atanackovic, MD5*, Nancy M. Hardy, MD4, Wengen Chen, PhD3*, Aaron P. Rapoport, MD4 and Saurabh Dahiya, MD4

1Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
2University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
3Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland Medical Center, Baltimore, MD
4Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD
5University of Maryland Medical Center, Baltimore, MD
6Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
7Division of Hematology/Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
8Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, MD

Cristiana Carniti1*, Chiara Monfrini2*, Vanessa Aragona2*, Martina Magni2*, Cristina Vella2*, Eugenio Fardella3*, Riccardo Betta3*, Anisa Bermema2*, Federico Stella4*, Anna Dodero2*, Annalisa Chiappella, MD5, Anna Guidetti5 and Paolo Corradini, MD5

1Laboratory of Hematology, Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
2Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
3Fondazione IRCCS Istituto Nazionale dei Tumori and Università degli Studi di Milano, Milano, Italy
4Università degli Studi di Milano, Milano, Italy
5Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

Sattva S. Neelapu, MD1, Rajneesh Nath, MD2, Javier Munoz, MD, MS, MBA, FACP2, Michael Tees, MD, MPH3, David B. Miklos, MD, PhD4, Matthew J. Frank, MD, PhD4, Shahbaz A. Malik, MD5, Don Stevens, MD6, Chu Ri Shin, MD7*, Arun Balakumaran, MD, PhD7, Lynn Loomis-Navale, MSc7*, Lovely Goyal, PhD7*, Anh Nguyen7* and Frederick L. Locke, MD8

1Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
2Banner MD Anderson Cancer Center, Gilbert, AZ
3Colorado Blood Cancer Institute/Sarah Cannon Research Institute, Denver, CO
4Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Hospital, Stanford, CA
5Bone Marrow Transplant and Cellular Therapy Program, Sarah Cannon Blood Cancer Center at St. David's South Austin Medical Center, Austin, TX
6Norton Cancer Institute, Louisville, KY
7Allogene Therapeutics, South San Francisco, CA
8Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Gray Jodon, MD1, Meryl Colton, MD1*, Diana Abbott, PhD2*, Anthony Cai, MD3*, Brad M. Haverkos, MD, MS, MPH4, Rustain Morgan, MD3* and Manali Kamdar, MD5

1University of Colorado Cancer Center, Aurora, CO
2Department of Biostatistics and Bioinformatics, University of Colorado Denver, Aurora, CO
3University of Colorado Anschutz Medical Campus, Aurora
4Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, Ohio State University, Aurora, CO
5Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO

Jae H Park, MD1, Sarah Nikiforow, MD, PhD2, Soyoung Kim, PhD3,4*, Zhen-Huan Hu, MPH3*, Amy Moskop, MD3, Sairah Ahmed, MD5, Muhammad Bilal Abid6*, Talha Badar, MD7, Christopher Bredeson, MD, FRCPC, MSc8, Valerie Brown9*, Mitchell S. Cairo, MD10, Miguel Díaz11*, Bhagirathbhai Dholaria, MBBS12, Siddhartha Ganguly13*, Natalie S Grover, MD14, Rabi Hanna, MD15, Peiman Hematti, MD16, Mira A Kohorst, MD17*, Hillard Lazarus18*, Lazaros J. Lekakis19*, Frederick L. Locke, MD20, Hemant S. Murthy, MD21, Alberto Mussetti22,23*, Michael A. Pulsipher, MD24, Muna Qayed, MD25*, Ran Reshef26*, David A Rizzieri, MD27, Maria Queralt Salas28*, Bipin Savani, MD29, Akshay Sharma, MBBS30, Kirk R. Schultz, MD31, Monica Thakar, MD32, Cameron Turtle33*, Jean A. Yared, MD34, John L. Wagner, MD35*, Xianmiao Qiu36*, Marcelo C Pasquini, MD, MS37 and Miguel-Angel Perales, MD38

1Memorial Sloan-Kettering Cancer Ctr., New York, NY
2Dana Farber Cancer Center, Boston, MA
3CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
4Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
5MD Anderson Cancer Center, Houston, TX
6Medical College of Wisconsin, Milwaukee, WI
7Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
8Hematology, Ottawa General Hospital, Ottawa, ON, Canada
9Penn State Hershey Children's Hospital, Hershey, PA
10Department of Pediatrics, New York Medical College, Valhalla, NY
11HOSPITAL Infantil Universitario Niño Jesus, MADRID, ESP
12Vanderbilt University Medical Center, Nashville, TN
13University of Kansas Health System, Kansas City, KS
14UNC Health Care, Chapel Hill, NC
15Department of Pediatric Hematology Oncology and BMT, Cleveland Clinic Children's, Cleveland, OH
16Division of Hematology/Oncology, University of Wisconsin School of Medicine & Public Health, Madison, WI
17Department of Pediatric Hematology-Oncology, Mayo Clinic, Rochester, MN
18University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH
19University of Miami, Miami, FL
20Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
21Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
22Institut Catalá d'Oncologia - Hospitalet, Barcelona, Barcelona, Spain
23IDIBELL-Institut Català d'Oncologia, l'Hospitalet de Llobregat, El Prat de Llobregat, Spain
24Division of Hematology, Oncology, Blood and Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA
25Emory University School of Medicine, Atlanta, GA
26Blood and Marrow Transplantation Program and Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY
27Dept. of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC
28Hospital Clinic de Barcelona, Barcelona, Spain
29Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Houston, TX
30Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
31British Columbia Children's Hospital, The University of British Columbia, Vancouver, BC, Canada
32Fred Hutchinson Cancer Research Center & University of Washington, Seattle, WA
33Fred Hutchinson Cancer Research Center, Seattle, WA
34Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, MD
35Thomas Jefferson University, Philadelphia, PA
36CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine,, Medical College of Wisconsin, Milwaukee, WI
37CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine,, Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
38Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH